Nikolaus R. McFarland, Ph.D.

Affiliations: 
1988-1992 University of Chicago, Chicago, IL 
 1992-2002 University of Rochester, Rochester, NY 
 2002-2006 Neurology University of Virginia School of Medicine, Charlottesville, VA, United States 
 2006-2010 Neurology Massachusetts General Hospital & Harvard Medical School, Boston, MA, United States 
 2010- Neurology University of Florida College of Medicine 
Area:
Parkinsonism, atypical parkinson disorders, neurodegenerative models, AAV
Website:
https://movementdisorders.ufhealth.org/team/faculty-fellows/nikolaus-mcfarland-m-d-ph-d/
Google:
"Nikolaus McFarland"
Mean distance: 15.59 (cluster 17)
 
SNBCP
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Hass EW, Sorrentino ZA, Lloyd GM, et al. (2021) Robust α-synuclein pathology in select brainstem neuronal populations is a potential instigator of multiple system atrophy. Acta Neuropathologica Communications. 9: 80
Tanner CM, Cummings SR, Schwarzschild MA, et al. (2021) The TOPAZ study: a home-based trial of zoledronic acid to prevent fractures in neurodegenerative parkinsonism. Npj Parkinson's Disease. 7: 16
Quattrone A, Antonini A, Vaillancourt DE, et al. (2020) A New MRI Measure to Early Differentiate Progressive Supranuclear Palsy From De Novo Parkinson's Disease in Clinical Practice: An International Study. Movement Disorders : Official Journal of the Movement Disorder Society
Archer DB, Mitchell T, Burciu RG, et al. (2020) Magnetic Resonance Imaging and Neurofilament Light in the Differentiation of Parkinsonism. Movement Disorders : Official Journal of the Movement Disorder Society
Nigro S, Antonini A, Vaillancourt DE, et al. (2020) Automated MRI Classification in Progressive Supranuclear Palsy: a Large International Cohort Study. Movement Disorders : Official Journal of the Movement Disorder Society
Julayanont P, Heilman KM, McFarland NR. (2020) Early-motor phenotype relates to neuropsychiatric and cognitive disorders in huntington's disease. Movement Disorders : Official Journal of the Movement Disorder Society
Archer DB, Bricker JT, Chu WT, et al. (2019) Development and validation of the automated imaging differentiation in parkinsonism (AID-P): a multicentre machine learning study. The Lancet. Digital Health. 1: e222-e231
Archer DB, Bricker JT, Chu WT, et al. (2019) Development and Validation of the Automated Imaging Differentiation in Parkinsonism (AID-P): A Multi-Site Machine Learning Study. The Lancet. Digital Health. 1: e222-e231
Julayanont P, McFarland NR, Heilman KM. (2019) Mild cognitive impairment and dementia in motor manifest Huntington's disease: Classification and prevalence. Journal of the Neurological Sciences. 408: 116523
Baudendistel ST, Schmitt AC, Rodriguez AV, et al. (2019) A turn for the worse: Turning performance in Parkinson's disease and Essential tremor. Clinical Biomechanics (Bristol, Avon). 70: 245-248
See more...